NEW YORK --(BUSINESS WIRE)--Aug. 18, 2022-- Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced the appointment of Geoffrey Porges , MBBS., as chief financial officer. Dr.
Software Revenue of $30.0 Million , a 25 Percent Increase Over Second Quarter of 2021 ; Total Revenue of $38.5 Million , up 29 Percent Over Second Quarter of 2021 Company Maintains Full-Year 2022 Financial Outlook Phase 1 Clinical Study of SGR-1505, Schrödinger’s MALT1 Inhibitor, On-Track to Begin
NEW YORK --(BUSINESS WIRE)--Jul. 21, 2022-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, will report its second quarter 2022 financial results on Thursday, August 4, 2022 , after the financial markets close.
Phase 1 Clinical Trial in Patients with Advanced B-Cell Malignancies Expected to Begin in the Second Half of 2022 NEW YORK --(BUSINESS WIRE)--Jun. 28, 2022-- Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered,
NEW YORK --(BUSINESS WIRE)--Jun. 22, 2022-- Schrödinger, Inc . (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today will host its second annual Educator’s Day , bringing together K-12 and university educators from across the
NEW YORK --(BUSINESS WIRE)--Jun. 2, 2022-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a fireside chat at the Jefferies Healthcare Conference .
NEW YORK --(BUSINESS WIRE)--May 19, 2022-- Schrödinger , Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced the appointment of Arun Oberoi to its Board of Directors, effective May 17, 2022 . Mr.
NEW YORK --(BUSINESS WIRE)--May 13, 2022-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will participate at the Citi Biotech Virtual Co-Panel Day.
Software Revenue of $33.1 Million , a 26 Percent Increase Over First Quarter of 2021 ; Total Revenue of $48.7 Million , up 51 Percent Over First Quarter of 2021 Company Maintains Full-Year 2022 Financial Outlook Internal Pipeline Progressing, With IND Submission for SGR-1505, Schrödinger’s MALT1
NEW YORK --(BUSINESS WIRE)--Apr. 20, 2022-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, will report its first quarter 2022 financial results on Wednesday, May 4, 2022 , after the financial markets close.